CDKN2A and Hyperglycemia: Hyperglycemia can cause the cessation of the cell cycle in endothelial cells through the action of cyclin-dependent kinase inhibitors, specifically p21CIP1 and p16INK4A [22], resulting in accelerated anti-senescence of endothelial cells.